We thank Dr. Julie Villanueva and Dr. James Johnson from the CDC Influenza Division for advice during the developmental stages of the Assay and critical review of the data, and Susan E. Hollingsworth and Hye-Joo Kim from the CRC Office of Regulatory Affairs for their valuable work during the 510K process, and the Puerto Rico Department of Health and the National Reference Laboratory of Costa Rica for their participation in the reproducibility studies. We also thank members of the CDC Dengue Branch Serology Laboratory and Epidemiology Activity whose previous work provided the characterized samples used in these studies; Luis Manuel Santiago for his statistical advice, and members of the CDC Arboviral Diseases Branch for sequencing of samples in this study.